Economic analysis and pharmaceutical policy.
Desflurane, the third generation inhalational anaesthetic agent. Meeting. Barcelona ESP, 1994/11/17.
Economic evaluation, a comparative analysis of alternative actions in terms of costs and consequences, allows rational decisions to be made concerning the deployment of resources (people, time, equipment, facilities and knowledge).
Pharmaceutical policy reflects the various objectives of the many social groups, some of which are conflicting.
While new methodologies for evaluation of health care programmes still need to gain wider acceptance, resource limitations for both care providers and decision makers make economic analysis an increasingly important tool.
Mots-clés Pascal : Economie santé, Analyse coût, Anesthésie, Homme, Politique sanitaire
Mots-clés Pascal anglais : Health economy, Cost analysis, Anesthesia, Human, Health policy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0009534
Code Inist : 002B27A06. Création : 01/03/1996.